Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Guanethidine monosulfate [antihypertensive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate 10mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate 3% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate 1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate 0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing guanethidine monosulfate and hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate+epinephrine 0.25%/0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate+epinephrine 1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanethidine monosulfate+adrenaline 0.5%/0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely guanethidine monosulfate 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guanethidine monosulfate 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guanethidine monosulfate 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guanethidine monosulfate 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
Has precise active ingredient |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
Has basis of strength substance (attribute) |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
Has precise active ingredient |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guanethidine monosulfate 10 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guanethidine monosulfate 10 milligram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate 10 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate 10 mg/mL solution for injection |
Has precise active ingredient |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
Has basis of strength substance (attribute) |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guanethidine monosulfate+adrenaline 3%/0.5% eye drops (substance) |
Has precise active ingredient |
True |
Guanethidine monosulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |